Stockscreener 앱 받기
1.37
0.72%
-0.010
시간 외 거래:
1.37
전일 마감가:
$1.38
열려 있는:
$1.425
하루 거래량:
3.11M
Relative Volume:
2.81
시가총액:
$148.61M
수익:
$4.35M
순이익/손실:
$-45.53M
주가수익비율:
-1.2685
EPS:
-1.08
순현금흐름:
$-44.79M
1주 성능:
+8.73%
1개월 성능:
+37.00%
6개월 성능:
+1.48%
1년 성능:
+76.16%
1일 변동 폭
$1.32
$1.5397
1주일 범위
$1.21
$1.5397
52주 변동 폭
$0.73
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
명칭
Lucid Diagnostics Inc
전화
212 949 4319
주소
360 MADISON AVENUE, NEW YORK
LUCD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.37 | 140.61M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
132.94 | 231.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.22 | 158.98B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
392.31 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.90 | 119.10B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.94 | 47.53B | 5.69B | 1.41B | 577.90M | 6.95 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 개시 | BTIG Research | Buy |
| 2021-11-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 개시 | Needham | Buy |
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
Will Lucid Diagnostics Inc. outperform during market ralliesRate Cut & Weekly Top Gainers Trade List - خودرو بانک
Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025 - PR Newswire
Detecting support and resistance levels for Lucid Diagnostics Inc.Rate Hike & AI Powered Buy and Sell Recommendations - Newser
Will Lucid Diagnostics Inc. bounce back from current supportJuly 2025 Selloffs & Verified High Yield Trade Plans - Newser
How to build a custom watchlist for Lucid Diagnostics Inc.2025 Price Action Summary & Expert Curated Trade Ideas - Newser
Needham reiterates Buy rating on Lucid Diagnostics stock after positive CAC meeting - Investing.com Nigeria
Lucid Diagnostics at Cantor Conference: Path to Medicare Coverage By Investing.com - Investing.com Canada
Lucid Diagnostics at Cantor Conference: Path to Medicare Coverage - Investing.com
Critical Medicare Coverage Review: Lucid Diagnostics to Host Call on EsoGuard Cancer Detection Test Future - Stock Titan
Will Lucid Diagnostics Inc. continue its uptrendCEO Change & Weekly Market Pulse Updates - Newser
BTIG raises Lucid Diagnostics stock price target to $2.50 on positive CMS meeting - Investing.com India
Lucid Diagnostics stock rises as Canaccord reiterates Buy rating - Investing.com
Published on: 2025-09-05 05:06:12 - Newser
Strategies to average down on Lucid Diagnostics Inc.2025 Year in Review & Fast Exit and Entry Strategy Plans - Newser
How to read the order book for Lucid Diagnostics Inc.2025 Trade Ideas & High Conviction Investment Ideas - Newser
What technical models suggest about Lucid Diagnostics Inc.’s comebackTrade Volume Summary & Growth Focused Investment Plans - Newser
Long term hold vs stop loss in Lucid Diagnostics Inc.Weekly Profit Summary & Long Hold Capital Preservation Tips - Newser
Exit strategy if you’re trapped in Lucid Diagnostics Inc.July 2025 Update & Accurate Technical Buy Alerts - Newser
Quantitative breakdown of Lucid Diagnostics Inc. recent moveWeekly Trend Recap & Capital Efficient Trade Techniques - Newser
How to use a screener to detect Lucid Diagnostics Inc. breakouts2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - Newser
Does Lucid Diagnostics Inc. show high probability of reboundMarket Performance Report & Long-Term Capital Growth Strategies - Newser
Can technical indicators confirm Lucid Diagnostics Inc.’s reversalIPO Watch & Target Return Focused Stock Picks - Newser
Portfolio Recap: What is Lucid Diagnostics Inc. s 5 year growth outlookShort Setup & Free Daily Entry Point Trade Alerts - خودرو بانک
What is Lucid Diagnostics Inc. s 5 year growth outlook2025 Volatility Report & Capital Protection Trading Alerts - خودرو بانک
Signal strength of Lucid Diagnostics Inc. stock in tech scanners2025 Breakouts & Breakdowns & Safe Entry Zone Identification - Newser
How high can Lucid Diagnostics Inc. stock goJuly 2025 WrapUp & Weekly Sector Rotation Insights - Newser
Aug Drivers: How much upside does Lucid Diagnostics Inc. have2025 Performance Recap & Capital Efficiency Focused Ideas - خودرو بانک
Is Lucid Diagnostics Inc. stock reversal real or fakeJuly 2025 Volume & AI Driven Price Forecasts - Newser
Will Lucid Diagnostics Inc. benefit from AI trends2025 Macro Impact & Community Consensus Stock Picks - خودرو بانک
Will Lucid Diagnostics Inc. outperform tech stocksJuly 2025 Macro Moves & Real-Time Volume Analysis - خودرو بانک
Bollinger Band Squeeze Points to Volatility in Lucid Diagnostics Inc.Quarterly Market Summary & AI Powered Market Entry Ideas - beatles.ru
What to do if you’re stuck in Lucid Diagnostics Inc.2025 Key Lessons & Weekly High Potential Stock Alerts - Newser
Will Lucid Diagnostics Inc. benefit from government policyJuly 2025 Selloffs & Weekly High Return Opportunities - khodrobank.com
Lucid Diagnostics Earnings Call: Optimism Amid Challenges - TipRanks
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results - ADVFN Brasil
Regression analysis insights on Lucid Diagnostics Inc. performanceTrade Entry Summary & Safe Entry Point Identification - Newser
PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results - ADVFN Brasil
Lucid Diagnostics Inc (LUCD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lucid Diagnostics Inc 주식 (LUCD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Matheis Dennis | Director |
May 20 '25 |
Buy |
1.29 |
187,098 |
242,292 |
187,098 |
| Matheis Dennis | Director |
May 21 '25 |
Buy |
1.32 |
129,684 |
171,520 |
316,782 |
| Matheis Dennis | Director |
May 22 '25 |
Buy |
1.32 |
33,218 |
43,795 |
350,000 |
0.78%
0.31%
자본화:
|
볼륨(24시간):